Puma Biotechnology Sees FY2026 Sales $214.000-$221.000M vs $220.000M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Puma Biotechnology (NASDAQ:PBYI) sees FY2026 sales of $214.000-$221.000 million vs $220.000 million analyst estimate.
Puma Biotechnology (NASDAQ:PBYI) sees FY2026 sales of $214.000-$221.000 million vs $220.000 million analyst estimate.